Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Target Therapeutics

This article was originally published in The Gray Sheet

Executive Summary

Files a patent infringement suit Nov. 9 in U.S. District Court in San Francisco against SciMed Life Systems and Cordis Endovascular Systems. The Fremont, California-based manufacturer alleges that SciMed's Venture intravascular infusion catheter and Transend guidewire and Cordis' Transit infusion catheter and Instinct steerable guidewire infringe Target's patent No. 4,739,768, "A Catheter for Guide-Wire Tracking." Patent "768 covers the principal technology in Target's FasTracker micro- catheters. The company seeks treble damages and a permanent injunction against the sale of Cordis' and SciMed's allegedly infringing products
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003083

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel